Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
Sara E Schad,Andrew Chow,Levi Mangarin,Heng Pan,Jiajia Zhang,Nicholas Ceglia,Justina X Caushi,Nicole Malandro,Roberta Zappasodi,Mathieu Gigoux,Daniel Hirschhorn,Sadna Budhu,Masataka Amisaki,Monica Arniella,David Redmond,Jamie Chaft,Patrick M Forde,Justin F Gainor,Matthew D Hellmann,Vinod Balachandran,Sohrab Shah,Kellie N Smith,Drew Pardoll,Olivier Elemento,Jedd D Wolchok,Taha Merghoub
DOI: https://doi.org/10.1084/jem.20212169
2022-06-06
Abstract:Transcription factors ThPOK and Runx3 regulate the differentiation of "helper" CD4+ and "cytotoxic" CD8+ T cell lineages respectively, inducing single positive (SP) T cells that enter the periphery with the expression of either the CD4 or CD8 co-receptor. Despite the expectation that these cell fates are mutually exclusive and that mature CD4+CD8+ double positive (DP) T cells are present in healthy individuals and augmented in the context of disease, yet their molecular features and pathophysiologic role are disputed. Here, we show DP T cells in murine and human tumors as a heterogenous population originating from SP T cells which re-express the opposite co-receptor and acquire features of the opposite cell type's phenotype and function following TCR stimulation. We identified distinct clonally expanded DP T cells in human melanoma and lung cancer by scRNA sequencing and demonstrated their tumor reactivity in cytotoxicity assays. Our findings indicate that antigen stimulation induces SP T cells to differentiate into DP T cell subsets gaining in polyfunctional characteristics.